NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637113. A total of 33 filers reported holding NABRIVA THERAPEUTICS PLC in Q2 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 191,028 | $317,000 | 0.06% |
| FRAZIER MANAGEMENT LLC | 425,650 | $707,000 | 0.06% |
| Values First Advisors, Inc. | 45,033 | $75,000 | 0.06% |
| SABBY MANAGEMENT, LLC | 164,007 | $272,000 | 0.05% |
| ABG Innovation Capital Partners III GP Ltd | 45,849 | $76,000 | 0.04% |
| CCG WEALTH MANAGEMENT, LLC | 10,480 | $17,000 | 0.02% |
| Virtu Financial LLC | 31,186 | $52,000 | 0.00% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 31,274 | $52,000 | 0.00% |
| WINTON GROUP Ltd | 33,211 | $55,000 | 0.00% |
| Squarepoint Ops LLC | 156,623 | $260,000 | 0.00% |